NCT02176577View on ClinicalTrials.gov

Study to Determine the Pharmacokinetics of Product 0405

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Atopic Dermatitis
Interventions
DRUG

Product 0405

Product 0405 will be administered topically, twice daily for 28 days.

Sponsors
All Listed Sponsors
lead

Fougera Pharmaceuticals Inc.

INDUSTRY

NCT02176577 - Study to Determine the Pharmacokinetics of Product 0405 | Biotech Hunter | Biotech Hunter